Study to Evaluate the Safety and Efficacy of Daratumumab and Carfilzomib-based Induction/Consolidation/Maintenance Therapy in Transplant-eligible, Ultra High-risk, Newly Diagnosed Multiple Myeloma
Clinical trial NCT06140966 · RECRUITING
Trial details
- NCT number
- NCT06140966
- Sponsor
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-20
- Primary completion
- 2026-10-20
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.